ARTERIAL HYPERTENSION IN RHEUMATOID ARTHRITIS

Авторы

  • Kamolova Diyora Djamshedovna Автор
  • Khusainova Munira Alisherovna Автор
  • Sultonov Ilkhom Islomovich Автор

Ключевые слова:

Keywords: rheumatoid arthritis, arterial hypertension, risk factors

Аннотация

ABSTRACT 
The aim is to assess the prevalence and risk factors of arterial hypertension (AH) 
in young and middle–aged rheumatoid arthritis (RA) patients. 
Material  and  methods.  222  RA  patients  (34%  with  early  RA)  without 
concomitant  cardiovascular  diseases  were  examined.  The  average  age  was  47±9.7 
years; men were 15%; 60% of patients were seropositive for rheumatoid factor (RF), 
the  average  value  of  DAS  28  was  5.77±1.1,  HAQ-DI  was  1.58±0.7.  Associations 
between risk factors and hypertension were analyzed using logistic regression models 
adjusted for gender and age. 
Results. Hypertension was found in 153 (69.4%) patients (55% in early RA). In 
56.3% of patients, an increase in blood pressure was first recorded after the debut of 
RA. With hypertension in RA, age (odds ratio [OR] 2.06; 95% confidence interval [CI] 
1.51–2.81), seropositivity in the Russian Federation (OR=3.05; 95% CI 1.67–5.57), 
abdominal obesity (OR=3.82; 95% CI 1.89–7.71), body mass index (BMI; OR= 1.15; 
95% CI 1.07–1.24) and long-term prednisone intake (OR = 1.17; 95% CI 1.03–1.33). 
In early RA, the predictors of hypertension were seropositivity in RF (OR=4.62; 95% 
CI 1.67–12.82), RF titer (OR=1.43; 95% CI 1.04–1.96), the number of swollen joints 
out of 28 (OR=1.14; 95% CI 1.03–1.27), DAS 28 (OR=1.64; 95% CI 1.001–2.67), 
HAQ-DI (OR=3.14; 95% CI 1.19–8.25) and BMI (OR=1.14; 95% CI 1.01–1.29). 
Conclusion. Hypertension is widespread in patients with RA, including in early RA. In 
more than half of cases, hypertension develops against the background of RA and is 
associated  with  traditional  risk  factors,  the  presence  of  RF  and  long-term  use  of 
prednisone. The contribution of RA characteristics to the development of hypertension 
is  most  clearly  seen  in  early  RA.  The  results  obtained  indicate  the  need  for  early 
diagnosis  and  effective  treatment  of  hypertension  in  RA  with  adequate  control  of 
inflammatory activity. 

Библиографические ссылки

LITERATURE

1. Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S. (2021).

The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending On The

C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic Science, 12(3), 2908-

2916.

2. Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT

RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 3-

8.

3. Ilkhom, S. (2023). CAJAM–VOLUME 1. ISSUE 1. 2023. Central Asian Journal

of Advanced Medicine, 1(01), 16-19.

4. Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные

проявления у больных системной красной волчанкой. Вопросы науки и

образования, (28 (77)), 128-131.

5. Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., &

Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in

Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-4150.

6. Kireev, V. V., & Sultonov, I. I. (2021). Genetic Engineered Preparations-An

Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the

Romanian Society for Cell Biology, 4114-4119.

7. Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus

erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.

8. Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ

ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ

МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник

науки и образования, (9-3 (87)), 86-91.

9. Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта

системной красной волчанки. Академический журнал Западной Сибири, 9(1),

15-15.

10. Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS TREATED

WITH DMARDS AND CARDIOVASCULAR DISEASE RISK. Oriental Journal

of Medicine and Pharmacology, 3(02), 45-52.

11. Нурматова, Л., Султонов, И., & Тоиров, Э. (2011). Эффективность препаратов

пищеварительной активности в комплексном лечении больных хроническим

гепатитом. Журнал проблемы биологии и медицины, (3 (66)), 107-110. 12. Sultonov, I. I., Khamrayev, X. X., & Xasanov, F. SYSTEMIC LUPUS

ERYTHEMATOSUS AND CARDIOVASCULAR PATHOLOGY: WHERE WE

AT?.

13. Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., &

Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control

Study. International journal of health sciences, 6(S10), 175-182.

14. Khusainova, M. A., Vakhidov, J. J., Khayitov, S. M., & Mamadiyorova, M. M.

(2023). Cardiac arrhythmias in patients with rheumatoid arthritis. Science and

Education, 4(2), 130-137.

15. Khusainova, M. A., Eshmamatova, F. B., Ismoilova, K. T., & Mamadiyorova, M.

M. (2023). METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS AS A

CRITERION OF CARDIOVASCULAR RISK. Oriental renaissance: Innovative,

educational, natural and social sciences, 3(1), 331-339.

16. Alisherovna, K. M., Ismatullayevich, M. A., & Nuriddinovna, E. N. (2024).

FEATURES OF HEART FAILURE IN PATIENTS WITH CORONARY HEART

DISEASE AND THYROTOXICOSIS. Ta'lim innovatsiyasi va

integratsiyasi, 19(4), 52-61.

17. Alisherovna, K. M., Yaxshiboyevich, U. M. R., & Yigitaliyevich, B. A. (2024).

EVALUATION OF A NATRIURETIC PEPTIDE TO OPTIMIZE THE

MANAGEMENT OF COMORBID PATIENTS WITH THYROTOXICOSIS

AND HEART FAILURE. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 62-70.

18. Alisherovna, K. M., Mansurovna, M. D., Erkinovna, N. D., Farxodovna, X. R.,

Toxirovna, M. M., Tolibovna, R. D., & Yorkinovna, E. N. (2024). ARTERIAL

HYPERTENSION AND THYROID STATUS IN PATIENTS OF DIFFERENT

AGES. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 122-129.

19. Alisherovna, K. M., Erkinovna, S. D., Yazdonkulovna, X. M., & Zafarovna, C. M.

M. (2024). ATRIAL FIBRILLATION IN THYROTOXICOSIS–

DETERMINANTS OF DEVELOPMENT AND CONSERVATION. Ta'lim

innovatsiyasi va integratsiyasi, 19(4), 103-113.

20. Alisherovna, K. M., Habibulloyevna, I. M., & Voxidovna, R. F. (2024).

STRUCTURAL AND FUNCTIONAL FEATURES OF THE LEFT VENTRICLE

IN PATIENTS WITH HEART FAILUREIN ISCHEMIC HEART DISEASE AND

THYROTOXICOSIS. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 71-81.

21. Davranovna, M. K. D. K., Alisherovna, K. M., & Erkinovna, K. Z. (2024).

CARDIAC ARRHYTHMIAS IN PATIENTS WITH RHEUMATOID

ARTHRITIS. Spectrum Journal of Innovation, Reforms and Development, 26, 65-

71.

22. Djamshedovna, K. D., Alisherovna, K. M., Xudoyberdiyevich, G. X., &

Rustamovich, T. D. (2023). EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN PREGNANT WOMEN. Spectrum Journal of Innovation, Reforms

and Development, 12, 137-144.

23. Djamshedovna, K. D., & Alisherovna, K. M. (2024). CHANGES IN SOME

SYSTEM INDICATORS IN PREGNANT WOMEN WITH GESTOSIS. Spectrum

Journal of Innovation, Reforms and Development, 25, 111-115.

24. Jamshedovna, K. D., Alisherovna, K. M., Erkinovna, K. Z., & Davranovna, M. K.

(2022). LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PREGNANT

WOMEN WITH PRE-ECLAMPSIA WITHOUT PROTEINURIA. Spectrum

Journal of Innovation, Reforms and Development, 10, 135-140.

25. Rustamovich, T. D., Alisherovna, K. M., Djamshedovna, K. D., &

Nizamitdinovich, K. S. (2023). Features of the psychoemotional status of patients

with rheumatoid arthritis. Miasto Przyszłości, 32, 23-30.

26. Alisherovna, K. M., Djamshedovna, K. D., Totlibayevich, Y. S., & Boymamatovna,

E. F. (2022). The Effectiveness of the Original Drug Trimetazidine MV in Patients

with Stable Ischemic Heart Disease and Persistent Angina Attacks Against the

Background of the Use of Trimetazidine Generics. Miasto Przyszłości, 30, 235-238.

27. Alisherovna, K. M., & Djamshedovna, K. D. (2024). AFTER COVID-19

QUALITY OF LIFE. Spectrum Journal of Innovation, Reforms and

Development, 25, 103-110.

28. Alisherovna, K. M., Jamshedovna, K. D., Totlibayevich, Y. S., &

Xudoyberdiyevich, G. X. (2022). FEATURES OF THE QUALITY OF LIFE OF

PATIENTS WITH CHRONIC RENAL FAILURE IN THE TREATMENT OF

HEMODIALYSIS. Spectrum Journal of Innovation, Reforms and Development, 7,

76-81.

29. Rustamovich, T. D., Alisherovna, K. M., Nizamitdinovich, K. S., & Djamshedovna,

K. D. (2022). Gastrointestinal conditions in rheumatoid arthritis patients. Texas

Journal of Medical Science, 15, 68-72.

30. Alisherovna, K. M., Totlibayevich, Y. S., Xudoyberdiyevich, G. X., &

Jamshedovna, K. D. (2022). EFFICACY OF DRUG-FREE THERAPY OF

HYPERTENSION DISEASES IN THE EARLY STAGE OF THE

DISEASE. Spectrum Journal of Innovation, Reforms and Development, 7, 82-88.

Опубликован

2024-10-22

Как цитировать

Kamolova Diyora Djamshedovna, Khusainova Munira Alisherovna, & Sultonov Ilkhom Islomovich. (2024). ARTERIAL HYPERTENSION IN RHEUMATOID ARTHRITIS . Ta’lim Innovatsiyasi Va Integratsiyasi, 31(2), 139-145. https://scientific-jl.org/index.php/tal/article/view/949

Наиболее читаемые статьи этого автора (авторов)